pharma midwest semaglutide New weight-loss drugs set to shake up in 2026. Plus, semaglutide's patent expiry across major emerging markets, including India, Brazil and China, is expected to open the field to generic manufacturers Demand Rising for 'Bootlegged' Weight-Loss

Vadim Borchenko, RN CEO and Founder Vadim Borchenko is a medical practitioner with over 30 years of experience in the healthcare field

Additionally, patients with diabetesregardless of medicationhave baseline increased UTI risk due to factors including impaired immune function, incomplete bladder emptying related to diabetic neuropathy, and historically elevated glucose levels that may have created favorable conditions for bacterial colonization

Weight stigma is linked to poorer mental health, so it is unsurprising that Ozempic users experiencing weight loss may experience improved mood

Clinicians also caution that dosing strategies are not interchangeable across formulations or strengths, and inappropriate dose adjustments can result in clinically meaningful errors